Edward Barnes, MD, from the University of North Carolina at Chapel Hill, discusses the presentation he made at the September 12 virtual regional meeting of Advances in Inflammatory Bowel Disease on managing...
Donald E. Fetterolf, MD, discusses the major advantage of amniotic membrane therapy: the ability of the allografts to attract stem cells to the region of the wound in order to rebuild damaged tissues.
